中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2015年
15期
198-201
,共4页
甘春霞%肖勇武%李燕云%冶兆军
甘春霞%肖勇武%李燕雲%冶兆軍
감춘하%초용무%리연운%야조군
高压氧%幽门螺旋杆菌%联合治疗%疗效观察
高壓氧%幽門螺鏇桿菌%聯閤治療%療效觀察
고압양%유문라선간균%연합치료%료효관찰
Hyperbaric oxygen%HP (helicobacter pylori)%Combined treatment%Observation of curative effect
目的:观察高压氧(HBO)联合药物治疗幽门螺旋杆菌(Hp)阳性患者的临床疗效。方法将116例Hp阳性患者随机分为高压氧联合药物组(n=58,治疗组)和单纯药物组(n=58,对照组),2个疗程后胃镜复查,比较两组患者治疗前后溃疡大小及Hp的检出率。结果与对照组比较,治疗组患者溃疡的大小及Hp检出率明显减小(P<0.05),有效率升高(94% vs 69%,P<0.05),复发率降低(13.20% vs 34.69%,P<0.05),差异有统计学意义(P<0.05)。结论高压氧联合药物治疗Hp阳性患者的疗效确切,复发率低,值得在临床推广应用。
目的:觀察高壓氧(HBO)聯閤藥物治療幽門螺鏇桿菌(Hp)暘性患者的臨床療效。方法將116例Hp暘性患者隨機分為高壓氧聯閤藥物組(n=58,治療組)和單純藥物組(n=58,對照組),2箇療程後胃鏡複查,比較兩組患者治療前後潰瘍大小及Hp的檢齣率。結果與對照組比較,治療組患者潰瘍的大小及Hp檢齣率明顯減小(P<0.05),有效率升高(94% vs 69%,P<0.05),複髮率降低(13.20% vs 34.69%,P<0.05),差異有統計學意義(P<0.05)。結論高壓氧聯閤藥物治療Hp暘性患者的療效確切,複髮率低,值得在臨床推廣應用。
목적:관찰고압양(HBO)연합약물치료유문라선간균(Hp)양성환자적림상료효。방법장116례Hp양성환자수궤분위고압양연합약물조(n=58,치료조)화단순약물조(n=58,대조조),2개료정후위경복사,비교량조환자치료전후궤양대소급Hp적검출솔。결과여대조조비교,치료조환자궤양적대소급Hp검출솔명현감소(P<0.05),유효솔승고(94% vs 69%,P<0.05),복발솔강저(13.20% vs 34.69%,P<0.05),차이유통계학의의(P<0.05)。결론고압양연합약물치료Hp양성환자적료효학절,복발솔저,치득재림상추엄응용。
Objective To observe clinical effect of the hyperbaric oxygen (HBO)combined drug treatment of helicobacter pylori (Hp)-positive patients.Methods116 cases of Hp positive patients were randomly into hyperbaric oxygen combined drug group (n=58, the treatment group) and simple drug group (n=58, the control group). After two courses oftreatment,we compared ulcer size and Hp detection rate of two groups of patients through thegastroscope before and after treatment. Results Compared with control group, ulcer sizes and Hp detection rate were significantly reduced (P<0.05),and there were higher effective rate(94% vs 69%,P<0.05) and lower relapse rate (13.20% vs 34.69%,P<0.05) in the treatment group. The difference was statistically significant(P<0.05).Conclusion The treatment of the hyperbaric oxygen (HBO) combined drug treatment of helicobacter pylori (Hp)-positive patients is effective, and its recurrence rate is low. Therefore, the method is worthy of clinical application.